Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence

Por Wang, Xiaochun, Goldstein, David, Crowe, Philip J, Yang, Jia-Lin
Publicado no Onco Targets Ther (2016)

Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma

Por Yang, Jia-Lin, Das Gupta, Romi, Goldstein, David, Crowe, Philip J.
Publicado no Int J Mol Sci (2017)

Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies

Por WANG, YI-SHAN, YANG, GUIQING, WANG, YUAN-YUAN, YANG, JIA-LIN, YANG, KE
Publicado em 2013

The Potential of panHER Inhibition in Cancer

Por Wang, Xiaochun, Batty, Kathleen M., Crowe, Philip J., Goldstein, David, Yang, Jia-Lin
Publicado no Front Oncol (2015)

Protein Markers in Colorectal Cancer: Predictors of Liver Metastasis

Por Berney, Christophe R., Fisher, Richard J., Yang, Jia-lin, Russell, Pamela J., Crowe, Philip J.
Publicado em 1999

Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma

Por Wang, Xiaochun, Goldstein, David, Crowe, Philip J., Yang, Mark, Garrett, Kerryn, Zeps, Nikolajs, Yang, Jia-Lin
Publicado no Oncotarget (2016)

Efficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell immunotherapy for advanced refractory lung cancer

Por WANG, YUAN-YUAN, WANG, YI-SHAN, LIU, TAO, YANG, KE, YANG, GUI-QING, LIU, HAN-CHEN, WANG, SHAN-SHAN, YANG, JIA-LIN
Publicado em 2013